Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Yearly Results - AstraZeneca Pharma

AstraZeneca Pharma

BSE: 506820|NSE: ASTRAZEN|ISIN: INE203A01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 22, 16:00
2626.45
-66.05 (-2.45%)
VOLUME 1,529
LIVE
NSE
Nov 22, 15:52
2626.70
-63.1 (-2.35%)
VOLUME 13,115
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011

Yearly Results of AstraZeneca Pharma

------------------- in Rs. Cr. -------------------
Mar '19 Mar '18 Mar '17 Mar '16 Mar '15
Net Sales/Income from operations 728.29 571.00 526.31 526.46 469.05
Other Operating Income -- -- 13.26 37.27 48.02
Total Income From Operations 728.29 571.00 539.57 563.73 517.07
EXPENDITURE
Consumption of Raw Materials 62.67 27.88 14.00 34.76 26.78
Purchase of Traded Goods 169.84 204.21 142.16 158.89 167.28
Increase/Decrease in Stocks -1.38 -51.00 17.51 5.42 6.01
Power & Fuel -- -- -- -- --
Employees Cost 197.40 153.53 163.48 169.35 159.84
Depreciation 14.92 14.74 15.83 17.43 15.28
Excise Duty -- -- -- -- --
Admin. And Selling Expenses 79.80 72.81 -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 148.66 117.28 173.04 178.91 168.57
P/L Before Other Inc. , Int., Excpt. Items & Tax 56.38 31.55 13.56 -1.01 -26.69
Other Income 16.29 12.25 19.64 6.77 5.85
P/L Before Int., Excpt. Items & Tax 72.66 43.80 33.20 5.76 -20.84
Interest -- -- -- -- --
P/L Before Exceptional Items & Tax 72.66 43.80 33.20 5.76 -20.84
Exceptional Items -- -- -- -- --
P/L Before Tax 72.66 43.80 33.20 5.76 -20.84
Tax 18.22 17.89 8.76 0.50 --
P/L After Tax from Ordinary Activities 54.44 25.91 24.44 5.26 -20.84
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 54.44 25.91 24.44 5.26 -20.84
Equity Share Capital 5.00 5.00 5.00 5.00 5.00
Reserves Excluding Revaluation Reserves 295.80 241.93 217.87 151.01 145.76
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 21.78 10.37 9.78 2.10 -8.34
Diluted EPS 21.78 10.37 9.78 2.10 -8.34
EPS After Extra Ordinary
Basic EPS 21.78 10.37 9.78 2.10 -8.34
Diluted EPS 21.78 10.37 9.78 2.10 -8.34
Public Share Holding
No Of Shares (Crores) -- -- -- -- 0.63
Share Holding (%) -- -- -- -- 25.00
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) -- -- -- -- 1.88
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- 100.00
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- 75.00
Notes
Source : Dion Global Solutions Limited

Results of AstraZeneca

  • News
  • Results
  • Estimates
  • Analysis
No news.

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for astrazenecapharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.